title: Continuous subcutaneous insulin infusion therapy for Type 1 diabetes mellitus in children.
abstract: OBJECTIVE
  Continuous subcutaneous insulin pump therapy (CSII or pump therapy) is a well-recognised treatment option for Type 1 diabetes mellitus (T1DM) in paediatrics. It is especially suited to children because it optimises control by improving flexibility across age-specific lifestyles. The NICE guidelines (2008) recognise that pump therapy is advantageous and that it should be utilised to deliver best practice. In Ireland, the National Clinical Program for Diabetes will increase the availability and uptake of CSII in children and thus more clinicians are likely to encounter children using CSII therapy.
  
  
  METHODS
  This is a narrative review which discusses the basic principles of pump therapy and focuses on aspects of practical management.
  
  
  RESULTS
  Insulin pump management involves some basic yet important principles which optimise the care of diabetes in children.
  
  
  CONCLUSIONS
  This review addresses the principles of insulin pump management in children which all health care professionals involved in caring for the child with diabetes, shoud be familiar with.
authors.affiliation: Department of Paediatric Endocrinology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
authors.forename: M
authors.initials: M
authors.lastname: Mavinkurve
authors.affiliation: Department of Paediatric Endocrinology, University Hospital Limerick, Limerick, Ireland.
authors.forename: A
authors.initials: A
authors.lastname: Quinn
authors.affiliation: Department of Paediatric Endocrinology, University Hospital Limerick, Limerick, Ireland. clodagh.ogorman@ul.ie.|Department of Paediatrics, Graduate Entry Medical School, University of Limerick, Limerick, Ireland. clodagh.ogorman@ul.ie.
authors.forename: C S
authors.initials: CS
authors.lastname: O'Gorman
mesh_terms: D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D007494:Ireland
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: Continuous subcutaneous insulin infusion; Insulin Pump Therapy; Paediatrics; Type 1 diabetes mellitus